G. Rapatz

614 total citations
12 papers, 463 citations indexed

About

G. Rapatz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, G. Rapatz has authored 12 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in G. Rapatz's work include Asthma and respiratory diseases (4 papers), Nail Diseases and Treatments (3 papers) and Respiratory and Cough-Related Research (3 papers). G. Rapatz is often cited by papers focused on Asthma and respiratory diseases (4 papers), Nail Diseases and Treatments (3 papers) and Respiratory and Cough-Related Research (3 papers). G. Rapatz collaborates with scholars based in Switzerland, Italy and Mexico. G. Rapatz's co-authors include C. Paul, L. Duteil, Catherine Queille‐Roussel, J.‐P. Ortonne, John Kottakis, Alicia Ramírez‐Rivera, Lazaros Sichletidis, Albert P. Aldenkamp, Y. Sturm and João Almeida and has published in prestigious journals such as Neurology, CHEST Journal and British Journal of Dermatology.

In The Last Decade

G. Rapatz

12 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Rapatz Switzerland 10 163 152 141 130 75 12 463
Daniele Rapino Italy 13 57 0.3× 133 0.9× 230 1.6× 74 0.6× 38 0.5× 27 454
Portia Goldsmith United Kingdom 10 163 1.0× 112 0.7× 19 0.1× 44 0.3× 35 0.5× 26 425
Wenjing Li China 13 89 0.5× 145 1.0× 48 0.3× 148 1.1× 6 0.1× 39 379
Michele Ramien Canada 14 307 1.9× 121 0.8× 27 0.2× 101 0.8× 21 0.3× 53 604
Alison Hofmann United States 8 61 0.4× 158 1.0× 31 0.2× 289 2.2× 9 0.1× 10 504
Roshan Gunathilake Australia 6 326 2.0× 45 0.3× 15 0.1× 152 1.2× 7 0.1× 12 473
Jordan Rosen United States 10 353 2.2× 97 0.6× 28 0.2× 149 1.1× 3 0.0× 25 479
Annica Önell Sweden 12 80 0.5× 245 1.6× 57 0.4× 318 2.4× 4 0.1× 13 495
Emine Baran Türkiye 11 113 0.7× 74 0.5× 6 0.0× 37 0.3× 8 0.1× 55 431
C. Baumgarten Germany 10 73 0.4× 229 1.5× 106 0.8× 180 1.4× 6 0.1× 25 419

Countries citing papers authored by G. Rapatz

Since Specialization
Citations

This map shows the geographic impact of G. Rapatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Rapatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Rapatz more than expected).

Fields of papers citing papers by G. Rapatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Rapatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Rapatz. The network helps show where G. Rapatz may publish in the future.

Co-authorship network of co-authors of G. Rapatz

This figure shows the co-authorship network connecting the top 25 collaborators of G. Rapatz. A scholar is included among the top collaborators of G. Rapatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Rapatz. G. Rapatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Humbert, Marc, et al.. (2008). Add‐on omalizumab improves day‐to‐day symptoms in inadequately controlled severe persistent allergic asthma. Allergy. 63(5). 592–596. 32 indexed citations
2.
Wang, Jixian, et al.. (2008). Missing item imputation for quality‐of‐life instruments with application to asthma quality‐of‐life questionnaires. Pharmaceutical Statistics. 8(1). 73–83. 1 indexed citations
3.
Donati, Filippo, Giuseppe Gobbi, Jaume Campistol, et al.. (2007). The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure. 16(8). 670–679. 54 indexed citations
4.
Donati, Filippo, G. Gobbi, Josep M. Campistol, et al.. (2006). Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology. 67(4). 679–682. 28 indexed citations
5.
DeWilde, Stephen, et al.. (2005). PAS4 THE COST OF ASTHMA EXACERBATIONS OF DIFFERENT SEVERITY LEVELS. Value in Health. 8(6). A31–A31. 2 indexed citations
6.
Queille‐Roussel, Catherine, et al.. (2001). The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. British Journal of Dermatology. 144(3). 507–513. 169 indexed citations
7.
Körting, Hans Christian, et al.. (2001). One week terbinafine 1% cream (Lamisil®) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. Medical Mycology. 39(4). 335–340. 28 indexed citations
8.
Eliraz, A, Alicia Ramírez‐Rivera, G. Rapatz, et al.. (2001). SIMILAR EFFICACY FOLLOWING FOUR WEEKS TREATMENT OF ASTHMATICS WITH FORMOTEROL 12 μG B.D. DELIVERED BY TWO DIFFERENT DRY POWDER INHALERS: DIFFERENCES IN INHALER HANDLING. International Journal of Clinical Practice. 55(3). 164–170. 19 indexed citations
10.
D’Urzo, Anthony, María Cristina De Salvo, Alicia Ramírez‐Rivera, et al.. (2001). In Patients With COPD, Treatment With a Combination of Formoterol and Ipratropium Is More Effective Than a Combination of Salbutamol and Ipratropium. CHEST Journal. 119(5). 1347–1356. 86 indexed citations
11.
Eliraz, A, Alicia Ramírez‐Rivera, Pietro Ferranti, et al.. (2001). Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.. PubMed. 55(3). 164–70. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026